Randomized Trial of Follow-up Strategies in Breast Cancer
NCT ID: NCT00156039
Last Updated: 2009-07-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
968 participants
INTERVENTIONAL
1997-01-31
2003-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Randomized Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer
NCT05365230
Hypofractionated Radiotherapy Post-Lumpectomy in Women With Node Negative Breast Cancer
NCT00156052
RCT of a Group Intervention for Women With a Family History of Breast Cancer
NCT00150917
Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing Lumpectomy
NCT05866458
Psychosocial Study on Breast Cancer Risk Assessment
NCT00234715
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Follow-up Strategy for Breast Cancer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed at least 12 months previously (range 9-15 months)
* Without evidence of active disease (i.e., stages IIIB and IV excluded)
* Free from any primary treatment complications
Exclusion Criteria
* Still experiencing complications of primary treatment (patients will become eligible once complications resolve provided they are within the 6 month window)
* Unable to identify an acceptable family physician to provide follow-up
* Language or literacy skills inconsistent with completing questionnaires
* Unable to comply with study protocol including completion of questionnaires
* Previously enrolled in a study which requires continued follow-up in specialist or peripheral clinics
* Actively followed at a cancer centre for another primary cancer
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Canadian Breast Cancer Initiative
UNKNOWN
Ontario Clinical Oncology Group (OCOG)
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cancer Outcomes Research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eva Grunfeld, MD
Role: STUDY_CHAIR
Cancer Care Nova Scotia
Mark Levine, MD
Role: PRINCIPAL_INVESTIGATOR
Ontario Clinical Oncology Group (OCOG)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Juravinski Cancer Centre
Hamilton, Ontario, Canada
Kingston Regional Cancer Centre
Kingston, Ontario, Canada
Ottawa Hospital - Integrate Cancer Program
Ottawa, Ontario, Canada
Thunder Bay Regional Health Sciences Centre
Thunder Bay, Ontario, Canada
Toronto Sunnybrook Hospital
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Grunfeld E, Levine MN, Julian JA, Coyle D, Szechtman B, Mirsky D, Verma S, Dent S, Sawka C, Pritchard KI, Ginsburg D, Wood M, Whelan T. Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol. 2006 Feb 20;24(6):848-55. doi: 10.1200/JCO.2005.03.2235. Epub 2006 Jan 17.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CBCRI-grant-010413
Identifier Type: -
Identifier Source: secondary_id
OCOG-1997-FUP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.